FreakOut Holdings, inc.
FreakOut Holdings, inc. (6094.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for FreakOut Holdings, inc. (6094.T), featuring income statements, balance sheets, and cash flow data.
FreakOut Holdings, inc. (6094.T) Income Statement & Financial Overview
Explore comprehensive income reports for FreakOut Holdings, inc. 6094.T, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $11.61B | $13.74B | $14.18B | $12.59B |
| Cost of Revenue | $8.35B | $10.04B | $10.23B | $9.14B |
| Gross Profit | $3.26B | $3.68B | $3.92B | $3.45B |
| Gross Profit Ratio | $0.28 | $0.27 | $0.28 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.30B | $3.55B | $3.54B | $3.67B |
| Operating Expenses | $3.30B | $3.55B | $3.89B | $3.67B |
| Total Costs & Expenses | $11.65B | $13.59B | $14.12B | $12.81B |
| Interest Income | $14.03M | $20.42M | $22.12M | $9.45M |
| Interest Expense | $41.23M | $37.42M | $49.77M | $0.00 |
| Depreciation & Amortization | $285.85M | $1.09B | $1.09B | $143.75M |
| EBITDA | $108.56M | $1.25B | $1.24B | -$79.25M |
| EBITDA Ratio | $0.009 | $0.09 | $0.09 | -$0.006 |
| Operating Income | -$38.81M | $159.00M | $57.00M | -$222.00M |
| Operating Income Ratio | -$0.003 | $0.01 | $0.004 | -$0.02 |
| Other Income/Expenses (Net) | -$179.70M | $438.00M | -$411.00M | $1.05B |
| Income Before Tax | -$218.51M | $597.00M | -$354.00M | $830.00M |
| Income Before Tax Ratio | -$0.02 | $0.04 | -$0.02 | $0.07 |
| Income Tax Expense | $71.56M | $134.00M | $114.00M | $273.00M |
| Net Income | -$229.98M | $436.00M | -$439.00M | $275.00M |
| Net Income Ratio | -$0.02 | $0.03 | -$0.03 | $0.02 |
| EPS | -$13.23 | $25.09 | -$24.91 | $15.61 |
| Diluted EPS | -$13.23 | $25.09 | -$24.91 | $15.61 |
| Weighted Avg Shares Outstanding | $17.38M | $17.38M | $17.62M | $17.62M |
| Weighted Avg Shares Outstanding (Diluted) | $17.38M | $17.41M | $17.62M | $17.62M |
The company's financials show resilient growth, with revenue advancing from $12.59B in Q3 2024 to $11.61B in Q2 2025. Gross profit remained healthy with margins at 28% in Q2 2025 compared to 27% in Q3 2024. Operating income hit -$38.81M last quarter, sustaining a consistent -0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $108.56M. Net income dropped to -$229.98M, while earnings per share reached -$13.23. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan